Trial Profile
Lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: the German STAR/STELLA cohort
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms STAR/STELLA
- 16 Sep 2015 New trial record
- 06 Nov 2014 Interim results in 1409 patients after 144 weeks' treatment presented at the 12th International Congress on Drug Therapy in HIV Infection.